Are you a Life Sciences SME working on – or looking to work on – new and innovative projects in the LLEP area? If so, you’ve landed on the right page!
Through the SoLSTICE programme, part-funded by the European Regional Development Fund (ERDF) and the East Midlands Academic Health Science Network, we offer support to SME’s to innovate products, services and processes.
To help you on your innovation journey this project offers high quality advisory support & the opportunity to attend a variety of events
Plus we have the following grants available:
Innovation Support Grants of up to £20,000 at an average contribution from us of 32.5%, to procure external suppliers, or to engage new specialist staff
Med Tech Trials Grants of up to £50,000 at a maximum contribution from us of 50% to support clinical trials and the evaluation of new products
Specialist Networking Grants of up to £3,000 at a contribution from us of up to 50% to help overcome barriers to engaging in sector specific events
WHY:
The aims of the project are focused on improving the economic performance of the Life Sciences sector within the locality of LLEP, by enabling SMEs to increase their competitive advantage through innovation and stimulating interaction between business, research entities and the NHS.
HOW:
By providing a mixture of access to high value cutting edge Life Science sector specific expertise; cross-sectoral expertise from universities; grant funding; and networking opportunities. The total cost of the project is £1,225,003 of which £612,502 is of ERDF value.
By providing a mixture of access to high value cutting edge Life Science sector specific expertise; cross-sectoral expertise from universities; grant funding; and networking opportunities. The total cost of the project is £1,225,003 of which £612,502 is of ERDF value.
RESULT:
This will enable established SMEs to flourish and grow by introducing new products and services that benefit from: innovations, identified clinical needs and incorporation or utilisation of cutting-edge technologies. New jobs will be created and new businesses will be established. The project’s ultimate success will be measured by the degree to which innovation is embedded in business.
This will enable established SMEs to flourish and grow by introducing new products and services that benefit from: innovations, identified clinical needs and incorporation or utilisation of cutting-edge technologies. New jobs will be created and new businesses will be established. The project’s ultimate success will be measured by the degree to which innovation is embedded in business.
PROJECT PARTNERS:
Led by Medilink EM in partnership with the East Midlands Academic Health Science Network.
Led by Medilink EM in partnership with the East Midlands Academic Health Science Network.